Osaka, Japan

Satoshi Adachi

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Nishinomiya, JP (2012 - 2017)
  • Osaka, JP (2020 - 2024)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Satoshi Adachi: Innovator in Medicinal Chemistry

Introduction

Satoshi Adachi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating neuropsychiatric diseases. With a total of 8 patents to his name, Adachi's work has garnered attention in both academic and industrial circles.

Latest Patents

Among his latest patents is a formulation involving substituted pyrazoles that exhibit serotonin 5-HT receptor activity. This invention relates to a medicament designed for treating neuropsychiatric diseases, comprising a compound of Formula (1) or a pharmaceutically acceptable salt thereof as an active ingredient. Another notable patent is for bicyclic pyridine derivatives, which provides innovative compounds represented by a specific formula.

Career Highlights

Satoshi Adachi has worked with notable companies such as Furuno Electric Company Limited and Sumitomo Pharma Co., Ltd. His experience in these organizations has allowed him to apply his expertise in developing groundbreaking medicinal compounds.

Collaborations

Adachi has collaborated with esteemed colleagues, including Hidefumi Yoshinaga and Yohei Ikuma. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Satoshi Adachi's contributions to medicinal chemistry and his innovative patents highlight his role as a key figure in the field. His work continues to influence the development of new treatments for neuropsychiatric conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…